Dr Reddy’s launches of Albendazole Tablets USP

Dr Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two.

31
Medicine
Picture: Pixabay

Dr Reddy’s Laboratories announced the launch of Albendazole Tablets, USP, a therapeutic equivalent generic version of Albenza Tablets, 200 mg,approved by the U.S. Food and Drug Administration (USFDA).

Albendazole is an anthelmintic drug indicated for:

  • Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium
  • Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus

The Albenza brand and generic had US sales of approximately $27 million MAT for the most recent twelve months ending in November 2020 according to IQVIA Health*.

Dr Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two.


Enter your email address:

Delivered by FeedBurner

Latest updates

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Go to main website, click here

Follow and connect with us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Subscribe here for daily updates
Loading